Table 1. Demographic and clinical characteristics of study participants.
| Descriptives | |
|---|---|
| n | 15 |
| Age, mean (sd) | 65.20 (4.51) |
| Gender, Male (%) | 14 (93.3) |
| BMI, mean (sd) | 27.65 (5.98) |
| Race, Caucasian/White (%) | 14 (93.3) |
| COPD Severity, n (%)a | |
| Mild [FEV1pp ≥ 80%] | 5 (33.3)a |
| Moderate [FEV1pp = 50–79%] | 7 (46.6) |
| Severe [FEV1pp 30–49%] | 2 (13.3) |
| ICS Use, Yes (%) | 2 (13.3) |
| Pack years of smoking, mean (sd) | 49.13 (19.6) |
| Current tobacco use, Yes (%) | 3 (20.0) |
| Diabetes, Yes (%) | 1 (6.7) |
| Edentulous, n (%) | 3 (20.0) |
| Current alcohol use, Yes (%) | 9 (60.0) |
| Gastroesophageal reflux disease, Yes (%) | 7 (46.7) |
| Proton pump inhibitor use, Yes (%) | 4 (26.7) |
| Oral steroid or antibiotic use in last 1 month, Yes (%) | 0 (0) |
| Last dental visit, less than or equal to 6 months (%) | 8 (53.3) |
| Lung cancer, n (%) | 14 (93.3) |
| Adenocarcinoma, n (%)b | 6 (40.0)b |
| Squamous Cell Carcinoma, n (%)b | 8 (53.3)b |
| Large Cell Neuroendocrine tumor, n (%) | 1 (6.7) |
| Unknown, n (%)c | 1 (6.7)c |
aOne subject did not have COPD by lung function criteria.
bSubject 12 had 3 lung tumors (2 adenocarcinomas, 1 squamous cell carcinoma), which are included here individually; 16 independent lung tumors were diagnosed in 14 subjects.
cOne surgery was cancelled for clinical reasons and no tissue diagnosis was made.